Clinical Trial Update: Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 1/2 trial of an RNActive-derived cancer vaccine in stage IIIB/IV non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• RNActive-derived cancer vaccine (RNActive-derived cancer vaccine)

Snippet

Sponsor: CureVac | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED